BOSTON -- Patients with severe, uncontrolled asthma had significantly higher odds of improvement in asthma-related sleep ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

Daryl Brown, who was prescribed the antidepressant Seroxat in childhood because of his Tourette’s syndrome and OCD, tells ...

Biohaven has surged driven by promising data from its troriluzole trials for spinocerebellar ataxia and ongoing OCD studies.

A search at the store earlier this year found illegal vapes, erectile dysfunction tablets, chewing tobacco and untaxed beer, ...

Cerebras is seeking to go public at a valuation of about $8 billion. There are several red flags why I won't invest in its ...

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD ...

We recently published a list of George Soros Net Worth and Top 10 Holdings in 2024. In this article, we are going to take a ...

TD Cowen analyst Yaron Werber has maintained their neutral stance on GMAB stock, giving a Hold rating yesterday. Yaron Werber’s rating ...

Global equity markets climbed higher at the end of the week as the FTSE was aided by the UK economy’s return to growth. Fresh ...